NexTech to Release Q1 Earnings on May 14th, 2020
NEW YORK and TORONTO, May 08, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), […]
Aemetis to Review 2020 First Quarter Financial Results on May 14, 2020
CUPERTINO, CA, May 08, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Aemetis, Inc. (NASDAQ: AMTX) announced that the company will […]
Clearside Biomedical Announces First Quarter 2020 Financial Results
ALPHARETTA, Ga., May 08, 2020 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments […]
Avista Corp. Reports Financial Results for First Quarter 2020, and Revises 2020 Earnings Guidance
SPOKANE, Wash., May 08, 2020 (GLOBE NEWSWIRE) — Avista Corp. (NYSE: AVA) today reported net income attributable to Avista Corp. […]
O2Micro Reports First Quarter 2020 Financial Results
GEORGE TOWN, Grand Cayman, May 08, 2020 (GLOBE NEWSWIRE) —Operational and Strategic Highlights:Q1 2020 revenue was 15.6 Million, up 22.1% […]
RedHill Biopharma Receives FDA Approval for COVID-19 Clinical Study with Opaganib in the U.S.
The randomized, double-blind, placebo-controlled study aims to enroll up to 40 patients with moderate-to-severe COVID-19 pneumonia in the U.S. —All six […]
Tecnoglass Reports First Quarter 2020 Results
– Ends Quarter with Strong Liquidity Position And Financial Flexibility –– Reports Record Backlog of $545.6 million –– Provides COVID-19 […]
Baudax Bio Reports First Quarter 2020 Financial Results
ANJESO™ Approved by FDA for the Management of Moderate to Severe Pain; ProductNow Available for Ordering and Delivery for CustomersStrengthened […]
Amicus Therapeutics Announces Virtual 2020 Annual Meeting of Shareholders
CRANBURY, N.J., May 08, 2020 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD), a global, patient-dedicated biotechnology company focused on discovering, […]
Axsome Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Update
Clinical successes highlight Axsome’s accelerated evolution into a leading CNS companyPositive pivotal Phase 2/3 results for AXS-05 in Alzheimer’s disease […]
